Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-17-058963

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Thomas Joe · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-10-31 Grant or award : show line 1 in the form Stock Option (Right to Buy) +25,000 $1.26 2027-10-31 25,000 25,000 D
Loading xslF345X03/doc4.xml…